Skip to content

Clinical Survey of Oticon Medical Healing Cap

C51 - Clinical Survey of Oticon Medical Healing Cap

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02274129
Enrollment
32
Registered
2014-10-24
Start date
2014-07-31
Completion date
2016-04-19
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conductive Hearing Loss, Mixed Hearing Loss, Unilateral Partial Deafness

Brief summary

This study investigates the use of a new healing cap which, through altered design and choice of material, has been improved when it comes to minimizing the risk of it falling off as well as increasing patient comfort.

Detailed description

This study will primarily investigate the use of a new healing cap, Healing cap II. The new healing cap has the same function as previous healing caps, but it soft instead of hard. Due to this, the healing cap is anticipated to not fall off as easily, but at the same time does not risk transferring larger forces than previously to the implant. Secondly, the patients will start using the sound processor 1-2 weeks after surgery. The implant stability will be monitored before and after loading by the use of resonance frequency analysis, an established method to evaluate and monitor osseointegrated implants.

Interventions

DEVICEHealing cap II

Healing cap II is used instead of the traditional healing cap as part of the surgical dressing after bone anchored hearing aid implant surgery

Sponsors

Oticon Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients eligible for treatment with a bone anchored hearing aid * 18 years or older

Exclusion criteria

* Inability to participate in follow-up * Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.

Design outcomes

Primary

MeasureTime frameDescription
Skin reactions according to HolgersAt time of sugical follow up visit (visit window of 7-14 days after surgery)Focus is on healing, post-operative complications and skin reactions after the first 7-14 days after surgery.

Secondary

MeasureTime frameDescription
Fitting of sound processor at surgical follow-up visitAt time of surgical follow up visit (visit window of 7-14 days after surgery)Implant stability is monitored before and after sound processor fitting through ISQ and clinical assessments.

Other

MeasureTime frameDescription
Implant stabilityDuration of study (12 months of enrollment)
Use of Healing cap IIAt the surgical visitEase of use of Healing cap II and effect on surgical dressing
Surgical timeRecorded at surgery visitTime taken to perform the surgery
Pain and numbnessDuration of study (12 months of enrollment)
Time of fitting and type of sound processorDuration of study (12 months of enrollment)
Skin healing at first follow-up visitAt time of surgical follow up visit (visit window of 7-14 days after surgery)
Surgical complicationsAt the surgical visitAny complications during and after surgery

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026